Dec 9 (Reuters) - CVS Health (CVS) on Tuesday forecast 2026 profit above Wall Street estimates and this year's projected earnings, signalling steady progress in the health conglomerate's turnaround plan.
CVS stock rose 5% in early trading on Tuesday.
The company in October projected double-digit earnings growth for 2026 after raising its 2025 profit forecast for the third time.
"We are closing out 2025 with meaningful momentum across our businesses and we expect another year of strong earnings growth in 2026," said Chief Financial Officer Brian Newman on Tuesday.
The company forecast 2026 adjusted profit to be in the range of $7.00 to $7.20 per share, compared with analysts' average estimate of $7.16, according to data compiled by LSEG.
It, however, expects total revenue of at least $400 billion next year, below analysts' average estimate of $419.26 billion.
CVS also raised its 2025 adjusted profit forecast to $6.60 to $6.70 per share from $6.55 to $6.65 previously.
(Reporting by Sneha S K in Bengaluru; Editing by Shinjini Ganguli)
latest_posts
- 1
See tonight’s solar storm unfold across the world - 2Doritos and Cheetos debut 'NKD' options, without artificial colors or flavors
- 3What's going on with Katseye? The Manon Bannerman hiatus drama, explained.
- 4CMA Awards 2025: Full list of nominations, from Entertainer of the Year to Album of the Year
- 5Figure out how to Team up with Your Auto Crash Legal advisor for Best Outcomes
- 3D Printers for Specialists
- Watch This Glacier Race into the Sea
- Europe could get 42 more days of summer by the year 2100 due to climate change
- Inside the alleged Russian operation to trigger anti-government protests in Angola
- Finding the Universe of Computer generated Reality: Individual Encounters
- NASA's Artemis 2 moon launch seen from space | Space photo of the day for April 2, 2026
- US FDA unveils new pathway to approve personalized therapies
- Palestinians protest against Israel's new death penalty law
- China Just Got A Lot Closer To Its First-Ever Manned Moon Landing
